Skip to main content
SpringerLink
Log in

Effect of continuous positive airway pressure (CPAP) therapy on IL-23 in patients with obstructive sleep apnea

  • Original Article
  • Published:
Immunologic Research Aims and scope Submit manuscript

Abstract

Obstructive sleep apnea syndrome (OSAS) is a common sleep disorder characterized by repeated episodes of apnea and hypopnea during sleep. Continuous positive airway pressure (CPAP) is the most effective method for treating OSAS and alleviating the patients’ symptoms. The aim of this study was to assess the effect of 3-month CPAP therapy on serum levels of IL-23 in patients with OSAS. Twenty-three patients with newly diagnosed moderate-to-severe OSAS who had not yet started nasal CPAP treatment were prospectively enrolled. All of the subjects underwent simple spirometry and an overnight sleep study. Twenty-seven healthy individuals without OSAS were also recruited as the control group. Serum IL-23 and C-reactive protein (CRP) levels were measured before and after 3 months of CPAP therapy. There was no significant difference between moderate and severe OSAS patients in IL-23 and CRP, but both parameters were significantly higher than control group. The CPAP treatment produced a significant decrease in the levels of the inflammatory mediators CRP and IL-23 in patients. Changes in IL-23 were positively correlated with changes in AHI and in CRP. In conclusion, based on these results, serum IL-23 levels reflect OSAS-related systemic inflammation and are a useful marker for improvement in OSAS following CPAP therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Lindberg E, Gislason T. Epidemiology of sleep related obstructive breathing. Sleep Med Rev. 2000;4:411–33.

    Article  CAS  PubMed  Google Scholar 

  2. Coughlin SR, Mawdsley L, Mugarza JA, Calverley PMA, Wilding JPH. Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J. 2004;25:735–41.

    Article  PubMed  Google Scholar 

  3. Marin JM, Carrizo SJ, Vicente E, Agusti AGN. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet. 2005;365:1046–53.

    Article  PubMed  Google Scholar 

  4. Botros N, Concato J, Mohsenin V, Selim B, Doctor K, Yaggi HK. Obstructive sleep apnea as a risk factor for type 2 diabetes. Am J Med. 2009;122:1122–7.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Can M, Acıkgoz S, Mungan G, Bayraktaroglu T, Kocak E, Guven B, Demirtas S. Serum cardiovascular risk factors in obstructive sleep apnea. Chest. 2006;129:233–7.

    Article  CAS  PubMed  Google Scholar 

  6. Ryan S, Taylor CT, McNicholas WT. Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation. 2005;112:2660–7.

    Article  CAS  PubMed  Google Scholar 

  7. Christou K, Markoulis N, Moulas AN, Pastaka C, Gourgoulianis KI. Reactive oxygen metabolites (ROMs) as an index of oxidative stress in obstructive sleep apnea patients. Sleep Breath. 2003;7(3):105–10.

    Article  PubMed  Google Scholar 

  8. Chen WS, Chang YS, Chang CC, Chang DM, Chen YH, Tsai CY, Chen JH. Management and risk reduction of rheumatoid arthritis in individuals with obstructive sleep apnea: a nationwide population-based study in Taiwan. Sleep. 2016;1:515–523.

    Google Scholar 

  9. Kang JH, Lin HC. Obstructive sleep apnea and the risk of autoimmune diseases: a longitudinal population-based study. Sleep Med. 2012;13:583–8.

    Article  PubMed  Google Scholar 

  10. Tang C, Chen S, Qian H, Huang W. Interleukin-23: as a drug target for autoimmune inflammatory diseases. Immunology. 2011;135:112–24.

    Article  Google Scholar 

  11. Ngiow SF, Teng MW, Smyth MJ. A balance of Interleukin-12 and -23 in cancer. Trends Immunol. 2013;34:548–55.

    Article  CAS  PubMed  Google Scholar 

  12. Croxford AL, Mair F, Becher B. IL-23: one cytokine in control of autoimmunity. Eur J Immunol. 2012;42:2263–73.

    Article  CAS  PubMed  Google Scholar 

  13. Gaffen SL, Jain R, Garg AV, Cua DJ. The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing. Nat Rev Immunol. 2014;14:585–600.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Ye J, Liu H, Zhang G, Li P, Wang Z, Huang S, Yang Q, Li Y. The treg/th17 imbalance in patients with obstructive sleep apnoea syndrome. Mediators Inflamm. 2012;2012:815308.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Iber C, Ancoli-Israel S, Chesson AL, Quan SF, for the American Academy of Sleep Medicine. The AASM manual 2007 for the scoring of sleep and associated events: rules, terminology, and technical specifications. Westchester: American Academy of Sleep Medicine; 2007.

    Google Scholar 

  16. Friedewald WT, Levy RI, Frederickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499–502.

    CAS  PubMed  Google Scholar 

  17. Lin QC, Chen LD, Yu YH, Liu KX, Gao SY. Obstructive sleep apnea syndrome is associated with metabolic syndrome and inflammation. Eur Arch Otorhinolaryngol. 2014;271:825–31.

    Article  PubMed  Google Scholar 

  18. Chami HA, Fontes JD, Vasan RS, Keaney JF, O’Connor GT, Larson MG, Benjamin EJ, Gottlieb DJ. Vascular inflammation and sleep disordered breathing in a community-based cohort. Sleep. 2013;36:763–8.

    PubMed  PubMed Central  Google Scholar 

  19. Guven SF, Turkkani MH, Ciftci B, Ciftci TU, Erdogan Y. The relationship between high-sensitivity C-reactive protein levels and the severity of obstructive sleep apnea. Sleep Breath. 2012;16:217–21.

    Article  PubMed  Google Scholar 

  20. Floss DM, Schröder J, Franke M, Scheller J. Insights into IL-23 biology: from structure to function. Cytokine Growth Factor Rev. 2015;26(5):569–78.

    Article  CAS  PubMed  Google Scholar 

  21. Ciprandi G, Cuppari C, Salpietro A, et al. Serum IL-23 strongly and inversely correlates with FEV1 in asthmatic children. Int Arch Allergy Immunol. 2012;159:183–6.

    CAS  PubMed  Google Scholar 

  22. Ciprandi G, Cuppari C, Salpietro A, et al. Serum IL-23 in asthmatic children. J Biol Regul. 2012;26:53–62.

    Google Scholar 

  23. di Stefano A, Caramori G, Gnemmi I, et al. T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients. Clin Exp Immunol. 2009;157:316–24.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Dong L, Xia JW, Gong Y, Chen Z, Yang HH, Zhang J, He J, Chen XD. Effect of lianhuaqingwen capsules on airway inflammation in patients with acute exacerbation ofchronic obstructive pulmonary disease. Evid Based Complement Alternat Med. 2014;2014:637969.

    PubMed  PubMed Central  Google Scholar 

  25. Yokoe T, Minoguchi K, Matsuo H, Oda N, Minoguchi H, Yoshino G, et al. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation. 2003;107:1129–34.

    Article  CAS  PubMed  Google Scholar 

  26. Xie X, Pan L, Ren D, Du C, Guo Y. Effects of continuous positive airway pressure therapy on systemic inflammation in obstructive sleep apnea: a meta-analysis. Sleep Med. 2013;14:1139–50.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biochemistry, Faculty of Medicine, Bulent Ecevit University, Zonguldak, Turkey

    Murat Can & Berrak Guven

  2. Department of Chest Diseases, Faculty of Medicine, Bulent Ecevit University, Zonguldak, Turkey

    Fırat Uygur & Hakan Tanrıverdi

  3. Department of Public Health, Faculty of Medicine, Bulent Ecevit University, Zonguldak, Turkey

    Bilgehan Acıkgoz

  4. Department of Emergency Medicine, Umraniye Education and Training Hospital, Zonguldak, Turkey

    Barıs Alper

Authors
  1. Murat Can
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fırat Uygur
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hakan Tanrıverdi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Bilgehan Acıkgoz
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Barıs Alper
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Berrak Guven
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Murat Can.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Can, M., Uygur, F., Tanrıverdi, H. et al. Effect of continuous positive airway pressure (CPAP) therapy on IL-23 in patients with obstructive sleep apnea. Immunol Res 64, 1179–1184 (2016). https://doi.org/10.1007/s12026-016-8869-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12026-016-8869-8

Keywords

Search

Navigation